Evidence map›Paper›PMID 37323936›Full record

ArticleBioMed research international2023

Bahareh Kordi, Esmaeil Roohparvar Basmenj, Hamidreza Majidiani, Gholam Basati, Dariush Sargazi, Naser Nazari, Morteza Shams

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Bahareh KordiDepartment of Agricultural Science, Technical and Vocational University (TVU), Tehran, Iran.ORCID https://orcid.org/0000-0002-9272-6137
Esmaeil Roohparvar BasmenjBiophysics Department, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.ORCID https://orcid.org/0000-0002-9099-7902
Hamidreza MajidianiDepartment of Basic Medical Sciences, Neyshabur University of Medical Sciences, Neyshabur, Iran.ORCID https://orcid.org/0000-0001-5568-1366
Gholam BasatiZoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran.ORCID https://orcid.org/0000-0002-4739-4567
Dariush SargaziVeterinary Medicine, Zabol Veterinary Network, Zabol, Sistan and Baluchistan, Iran.ORCID https://orcid.org/0009-0004-7897-4005
Naser NazariDepartment of Parasitology and Mycology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.ORCID https://orcid.org/0000-0001-7989-1536
Morteza ShamsZoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran.ORCID https://orcid.org/0000-0001-7124-4908
Medical University of Ilam · IRKermanshah University of Medical Sciences · IRTarbiat Modares University · IRTechnical and Vocational University · IRUniversity of Neyshabur · IRZabol University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Visceral leishmaniasis is a life-threatening infectious disease worldwide. Extensive experiments have been done to introduce potential vaccine candidates to combat leishmaniasis. The present study was done to evaluate

Indexed as

Leishmania donovaniVaccinesAnimalsComputational BiologyDogsEpitopes, B-LymphocyteEpitopes, T-LymphocyteHumansMolecular Docking SimulationPeptidesVaccines, SubunitEpitopes, B-LymphocyteEpitopes, T-LymphocytePeptidesVaccinesVaccines, Subunit

Identifiers

PMID37323936
PMCPMC10266922
OpenAlexW4379644882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.